𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Interferon for Hepatitis B: Which Populations Benefit the Most

✍ Scribed by Michael Chang; Sammy Saab


Book ID
107540584
Publisher
Current Science Inc.
Year
2011
Tongue
English
Weight
194 KB
Volume
10
Category
Article
ISSN
1540-3416

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Benefits and risks of interferon therapy
✍ Robert Perrillo πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 120 KB

Alpha interferon is the only licensed drug for hepatitis B with immunomodulatory as well as viral inhibitory properties. Potential advantages of interferon compared to nucleoside analogs include a lack of drug resistance, a finite and defined treatment course, and a higher likelihood for hepatitis B